| Literature DB >> 28822541 |
M S Gilbert1, J J G C van den Borne2, C G van Reenen3, W J J Gerrits2.
Abstract
High interindividual variation in growth performance is commonly observed in veal calf production and appears to depend on milk replacer (MR) composition. Our first objective was to examine whether variation in growth performance in healthy veal calves can be predicted from early life characterization of these calves. Our second objective was to determine whether these predictions differ between calves that are fed a high- or low-lactose MR in later life. A total of 180 male Holstein-Friesian calves arrived at the facilities at 17 ± 3.4 d of age, and blood samples were collected before the first feeding. Subsequently, calves were characterized in the following 9 wk (period 1) using targeted challenges related to traits within each of 5 categories: feeding motivation, digestion, postabsorptive metabolism, behavior and stress, and immunology. In period 2 (wk 10-26), 130 calves were equally divided over 2 MR treatments: a control MR that contained lactose as the only carbohydrate source and a low-lactose MR in which 51% of the lactose was isocalorically replaced by glucose, fructose, and glycerol (2:1:2 ratio). Relations between early life characteristics and growth performance in later life were assessed in 117 clinically healthy calves. Average daily gain (ADG) in period 2 tended to be greater for control calves (1,292 ± 111 g/d) than for calves receiving the low-lactose MR (1,267 ± 103 g/d). Observations in period 1 were clustered per category using principal component analysis, and the resulting principal components were used to predict performance in period 2 using multiple regression procedures. Variation in observations in period 1 predicted 17% of variation in ADG in period 2. However, this was mainly related to variation in solid feed refusals. When ADG was adjusted to equal solid feed intake, only 7% of the variation in standardized ADG in period 2, in fact reflecting feed efficiency, could be explained by early life measurements. This indicates that >90% of the variation in feed efficiency in later life could not be explained by early life characterization of the calves. It is speculated that variation in health status explains a substantial portion of variation in feed efficiency in later life. Significant relations between fasting plasma glucose concentrations, fecal pH, drinking speed, and plasma natural antibodies in early life (i.e., not exposed to the lactose replacer) and feed efficiency in later life depended on MR composition. These measurements are therefore potential tools for screening calves in early life on their ability to cope with MR varying in lactose content.Entities:
Keywords: feed efficiency; glycerol; growth performance; lactose; veal calf
Mesh:
Substances:
Year: 2017 PMID: 28822541 PMCID: PMC7094503 DOI: 10.3168/jds.2016-12390
Source DB: PubMed Journal: J Dairy Sci ISSN: 0022-0302 Impact factor: 4.034
Ingredient and nutrient composition of the experimental milk replacers
| Item | Period 1 | Period 2 | |
|---|---|---|---|
| Ingredient, g/kg | |||
| Lactose or lactose replacement | 250.0 | ||
| Whey | 466.1 | 201.9 | |
| Delactosed whey | 149.7 | 150.0 | |
| Whey protein concentrate | 111.3 | 85.2 | |
| Soy protein concentrate | 10.0 | 62.5 | |
| Soluble wheat protein | 64.1 | 38.6 | |
| Fat | |||
| Lard | 52.5 | 64.6 | |
| Tallow | 52.5 | 64.6 | |
| Coconut oil | 49.2 | 34.9 | |
| Lecithin | 5.0 | 5.2 | |
| Emulsifier | 5.0 | 5.2 | |
| Premix | 10.0 | 10.0 | |
| Calcium formate | 8.4 | 7.5 | |
| Mono ammonium phosphate | 5.7 | ||
| Lysine | 10.0 | 6.7 | |
| Methionine | 2.1 | 3.1 | |
| Threonine | 2.0 | 1.6 | |
| CaCO3 | 2.5 | 2.5 | |
| Nutrient, g/kg of DM unless noted | Control | GFG | |
| DM, g/kg | 978 | 980 | 973 |
| Crude ash | 86 | 63 | 63 |
| CP, N × 6.25 | 207 | 180 | 181 |
| Crude fat | 193 | 205 | 187 |
| Lactose | 473 | 504 | 266 |
| Fe, mg/kg of DM | 45.9 | 12.2 | 12.9 |
In period 2, 2 milk replacers were used. In the GFG milk replacer, lactose was replaced by 100 g/kg of glucose, 50 g/kg of fructose, and 97.8 g/kg of glycerol. The amount of glycerol was slightly adjusted to match the gross energy content of the combination of glucose, fructose, and glycerol with that of the replaced lactose. Gross energy content was 15.6 kJ/g for lactose, 14.0 kJ/g for glucose, 15.4 kJ/g for fructose, and 17.6 kJ/g for glycerol.
The starter premix provided (per kg of experimental diet) CP, 0.7 g; starch, 5.0 g; crude ash, 1.5 g; calcium, 16.6 mg; phosphorus, 7.5 mg; sodium, 0.7 mg; potassium, 7.3 mg; chloride, 13.1 mg; magnesium, 0.5 g; iron, 44 mg; copper, 8.0 mg; zinc, 110 mg; manganese, 43 mg; selenium, 0.3 mg; iodide, 1.0 mg; vitamin A, 25,013 IU; vitamin D3, 4,002 IU; vitamin E, 135 mg; vitamin C, 0.3 g; vitamin K3, 2.1 mg; vitamin B1, 8.2 mg; vitamin B2, 10.2 mg; vitamin B3, 34.9 mg; vitamin B5, 18.0 mg; vitamin B6, 10.0 mg; vitamin B12, 0.1 mg; biotin, 0.2 mg; choline, 0.4 g; and folic acid, 0.7 mg.
The finisher premix provided (per kg of experimental diet) CP, 0.8 g; starch, 5.4 g; crude ash, 1.3 g; calcium, 17.0 mg; phosphorus, 8.1 mg; sodium, 0.8 mg; potassium, 7.8 mg; chloride, 13.2 mg; magnesium, 0.5 g; iron, 0.3 mg; copper, 4.0 mg; zinc, 100 mg; manganese, 43 mg; selenium, 0.3 mg; iodide, 1.0 mg; vitamin A, 25,000 IU; vitamin D3, 4,000 IU; vitamin E, 90 mg; vitamin C, 0.1 g; vitamin K3, 2.1 mg; vitamin B1, 8.2 mg; vitamin B2, 10.2 mg; vitamin B3, 34.8 mg; vitamin B5, 18.0 mg; vitamin B6, 6.2 mg; vitamin B12, 0.1 mg; biotin, 0.2 mg; choline, 0.4 g; and folic acid, 0.7 mg.
In the GFG milk replacer, glycerol was liquid and added separately when milk was prepared. The milk replacer powder without glycerol was analyzed on nutrient content. Glycerol was assumed to contain 995 g/kg of glycerol and 5 g/kg of moisture based on product specifications.
Calculated content.
Descriptive data of measurements performed in early life of calves (n = 117)
| Item | Mean | SD | CV |
|---|---|---|---|
| Arrival | |||
| Hematocrit, % | 33.5 | 5.80 | 17.3 |
| Hemoglobin, mmol/L | 6.2 | 1.09 | 17.6 |
| IgG titer | 3.2 | 1.38 | 42.7 |
| IgM titer | 4.3 | 1.53 | 35.1 |
| Feeding motivation | |||
| Milk replacer, kg | 10.4 | 1.16 | 11.2 |
| Concentrates, kg | 0.32 | 0.24 | 74.0 |
| Drinking speed, kg of milk replacer/min | 4.4 | 1.74 | 39.2 |
| Digestion | |||
| Fecal DM content, g/kg | 179 | 26.8 | 15.0 |
| Fecal pH | 7.3 | 0.32 | 4.3 |
| Fecal consistency score | 3.1 | 0.36 | 11.5 |
| Fecal color score | 3.8 | 0.30 | 7.9 |
| Total-tract retention time, h | 12.2 | 1.77 | 14.4 |
| Postabsorptive metabolism | |||
| Meal challenge | |||
| Basal glucose, mmol/L | 5.3 | 0.50 | 9.4 |
| Δ Glucose (basal to peak), mmol/L | 2.8 | 1.37 | 48.4 |
| Basal | 0.6 | 0.25 | 44.7 |
| Δ | 0.5 | 0.31 | 60.8 |
| Basal insulin, μg/L | 0.18 | 0.09 | 52.3 |
| Δ Insulin (basal to peak), μg/L | 7.3 | 6.48 | 88.9 |
| Basal NEFA | 0.17 | 0.08 | 46.5 |
| Δ NEFA (basal to 1 h), mmol/L | 0.07 | 0.07 | 89.7 |
| Fasting challenge | |||
| Δ Glucose (15 to 24 h), mmol/L | 1.2 | 0.28 | 23.3 |
| Fasting glucose (24 h), mmol/L | 3.8 | 0.46 | 12.2 |
| Δ NEFA (15 to 24 h), mmol/L | 0.11 | 0.13 | 112.9 |
| Fasting NEFA (24 h), mmol/L | 0.45 | 0.12 | 27.7 |
| Δ 13C urea (6 to 15 h), atom % | 0.027 | 0.009 | 34.2 |
| Immunology | |||
| IgG specific to HuSa, maximum response, titer | 5.5 | 1.53 | 27.6 |
| IgM specific to HuSa, maximum response, titer | 1.3 | 0.93 | 69.0 |
| Behavior and stress | |||
| Human approach test | |||
| Approach phase, | 0.1 | ||
| Touch phase, | 2.9 | ||
| Restraint test | |||
| Basal cortisol, nmol/L | 2.3 | 3.19 | 137.7 |
| Δ Cortisol, nmol/L | 2.1 | 4.63 | 221.4 |
| Behavior during weighing | |||
| Toward weighing scale, | 3.7 | ||
| On weighing scale, | 1.4 | ||
| Activity, % of time standing | 12.0 | 4.28 | 35.6 |
| Other | |||
| IGF-1, μg/L | 146.3 | 41.71 | 28.5 |
| Calf shape, cm2/kg of BW | 137.2 | 5.0 | 3.7 |
For fecal DM content and pH, n = 100. For retention time, n = 76. For the feeding motivation test with milk replacer and for drinking speed, n = 106. For all variables regarding postabsorptive metabolism, n = 115 except for Δ 13C urea (6 to 15 h), where n = 113. For the human approach test, restraint test, and behavior during weighing, n = 116. For the human serum albumin (HuSa) challenge, n = 105 for IgG and n = 106 for IgM.
NEFA = nonesterified fatty acids.
The human approach test was performed twice and the 2 scores were averaged per phase. For the approach phase, the number of calves with score 0, 0.5, and 1 were 105, 9, and 3, respectively. For the touch phase, 11 calves scored 1, 8 calves scored 1.5, 8 calves scored 2, 16 calves scored 2.5, 25 calves scored 3, 19 calves scored 3.5, and 30 calves scored 4.
For the behavior toward the weighing scale, the number of calves with score 1, 2, 3, 4, and 5 were 0, 2, 63, 24, and 28, respectively. For the behavior on the weighing scale, the number of calves with score 1, 2, 3, and 4 were 84, 23, 8, and 2, respectively.
Loadings per principal component (PC) extracted by principal component analysis performed separately per category in veal calves1
| Item | PC1 | PC2 | PC3 | PC4 | PC5 |
|---|---|---|---|---|---|
| Arrival | Hemoglobin and hematocrit | Natural antibodies | |||
| Hematocrit, % | −0.02 | ||||
| Hemoglobin, mmol/L | −0.04 | ||||
| IgG titer | 0.04 | ||||
| IgM titer | −0.09 | ||||
| Eigenvalue | 1.98 | 1.61 | |||
| Variance explained, % | 49.5 | 40.2 | |||
| Feeding motivation | Feeding motivation | Drinking speed | |||
| Feeding motivation milk replacer, kg | −0.14 | ||||
| Feeding motivation concentrates, g | 0.16 | ||||
| Drinking speed, kg of milk replacer/min | 0.01 | ||||
| Eigenvalue | 1.27 | 1.01 | |||
| Variance explained, % | 42.4 | 33.8 | |||
| Digestion | Fecal pH | Fecal DM | |||
| Fecal DM, g/kg | −0.06 | ||||
| Fecal pH | −0.15 | ||||
| Fecal consistency score | |||||
| Fecal color score | −0.04 | ||||
| Eigenvalue | 1.51 | 1.10 | |||
| Variance explained, % | 37.7 | 27.4 | |||
| Postabsorptive metabolism | Postprandial response | Fasting glucose and NEFA | Fasting glucose | Lactate and basal insulin | Urea production |
| Basal glucose, mmol/L | −0.04 | −0.14 | 0.07 | 0.04 | |
| Δ Glucose (0 to peak), mmol/L | −0.29 | −0.13 | −0.07 | −0.11 | |
| Basal | 0.06 | −0.09 | 0.10 | −0.07 | |
| Δ | 0.01 | 0.07 | − | −0.19 | |
| Basal insulin, μg/L | 0.01 | 0.30 | 0.34 | −0.14 | |
| Δ Insulin (0 to peak), μg/L | −0.28 | 0.09 | −0.12 | −0.27 | |
| Basal NEFA, mmol/L | 0.08 | −0.09 | −0.02 | 0.20 | |
| Δ NEFA (0 to 1 h), mmol/L | 0.07 | −0.08 | −0.05 | 0.27 | |
| Δ Glucose (15 to 24 h), mmol/L | −0.35 | 0.21 | 0.11 | −0.05 | |
| Fasting glucose (24 h), mmol/L | 0.32 | − | 0.01 | 0.12 | |
| Δ NEFA (15 to 24 h), mmol/L | −0.34 | 0.05 | 0.03 | 0.01 | |
| Fasting NEFA (24 h), mmol/L | 0.13 | −0.05 | −0.02 | −0.10 | |
| Δ 13C urea (6 to 15 h), atom % | 0.09 | −0.11 | 0.03 | −0.02 | |
| Eigenvalue | 3.28 | 2.23 | 1.68 | 1.59 | 1.10 |
| Variance explained, % | 25.3 | 17.1 | 12.9 | 12.3 | 8.4 |
| Behavior and stress | Reactivity | Fearfulness | Stress and activity | Acute stress | |
| Human approach test, approach phase, score (0 or 1) | −0.05 | 0.11 | −0.12 | ||
| Human approach test, touch phase, score (1 to 5) | −0.15 | 0.10 | −0.05 | ||
| Restraint test, basal cortisol, nmol/L | 0.00 | −0.22 | − | 0.22 | |
| Restraint test, Δ cortisol, nmol/L | −0.06 | 0.03 | 0.02 | ||
| Behavior toward weighing scale, score (1 to 5) | 0.12 | −0.04 | 0.06 | ||
| Behavior on weighing scale, score (1 to 4) | 0.30 | −0.06 | 0.09 | ||
| Activity, % of time standing | 0.08 | −0.16 | 0.24 | ||
| Eigenvalue | 1.27 | 1.22 | 1.18 | 1.03 | |
| Variance explained, % | 18.1 | 17.4 | 16.8 | 14.8 |
The eigenvalue and percentage of variance explained per PC are provided. Loadings >0.4 and <−0.4 are in bold.
NEFA = nonesterified fatty acids.
Effects of principal components (PC) and measurements from period 1 (experimental wk 1–9) and interaction with milk replacer treatment on ADG and adjusted ADG in period 2 (experimental wk 10–26) in veal calves fed a milk replacer containing lactose as the only carbohydrate source (control; n = 62) or a milk replacer in which 51% of the lactose was replaced by isoenergetic amounts of glucose, fructose, and glycerol (GFG; n = 55)
| Item | ADG period 2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | β (control) | β (GFG treatment) | ||||||||
| Item | Interaction | Estimate | SE | Estimate | SE | Estimate | SE | |||
| ADG period 2 | ||||||||||
| Treatment | 0.085 | |||||||||
| Feeding motivation PC2 (drinking speed) | 0.003 | −29.2 | 9.5 | |||||||
| Arrival PC2 (natural antibodies) | 0.044 | −19.1 | 9.4 | |||||||
| Behavior and stress PC1 (reactivity) | 0.908 | 0.052 | −19.7 | 12.0 | 0.102 | 17.5 | 14.7 | 0.235 | ||
| Behavior and stress PC2 (fearfulness) | 0.032 | −20.1 | 9.3 | |||||||
| IGF-1 | 0.003 | 0.7 | 0.2 | |||||||
| IgM specific to human serum albumin | 0.021 | 23.9 | 10.2 | |||||||
| Adjusted ADG period 2 | ||||||||||
| Treatment | 0.101 | |||||||||
| Postabsorptive metabolism PC3 (fasting glucose) | 0.579 | 0.035 | −18.0 | 8.9 | 0.044 | 10.6 | 10.0 | 0.293 | ||
| Digestion PC1 (fecal pH) | 0.825 | 0.057 | 14.6 | 9.0 | 0.106 | −11.6 | 10.2 | 0.260 | ||
| Feeding motivation PC2 (drinking speed) | 0.063 | 0.088 | −24.8 | 10.2 | 0.016 | −1.1 | 9.3 | 0.909 | ||
| Arrival PC2 (natural antibodies) | 0.602 | 0.095 | −14.9 | 8.5 | 0.083 | 7.8 | 10.5 | 0.457 | ||
Interaction between item and milk replacer treatment.
Adjusted ADG was calculated as the ADG adjusted for solid feed intake (see text for details).
Loadings per secondary principal component (sPC) extracted by secondary principal component analysis1
| Item | sPC1 | sPC2 | sPC3 | sPC4 | sPC5 | sPC6 | sPC7 | sPC8 | sPC9 | sPC10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrival PC1 | −0.03 | 0.33 | 0.10 | −0.28 | −0.26 | −0.10 | −0.02 | 0.05 | 0.13 | |
| Arrival PC2 | 0.01 | −0.02 | 0.04 | 0.04 | −0.02 | −0.05 | 0.05 | −0.01 | −0.03 | |
| Feeding motivation PC1 | 0.02 | −0.05 | 0.03 | 0.03 | −0.01 | 0.00 | −0.04 | −0.14 | −0.02 | |
| Feeding motivation PC2 | −0.30 | 0.01 | −0.25 | 0.03 | −0.07 | −0.01 | −0.05 | −0.19 | −0.03 | |
| Digestion PC1 | 0.40 | −0.03 | 0.37 | 0.23 | 0.19 | 0.00 | −0.31 | 0.00 | −0.21 | |
| Digestion PC2 | 0.06 | −0.06 | −0.23 | −0.19 | −0.03 | −0.34 | −0.08 | −0.02 | −0.30 | |
| Postabsorptive metabolism PC1 | 0.04 | 0.07 | 0.04 | −0.10 | 0.16 | −0.24 | 0.00 | 0.28 | 0.03 | |
| Postabsorptive metabolism PC2 | −0.15 | 0.10 | −0.06 | 0.02 | −0.02 | 0.16 | 0.00 | 0.03 | 0.01 | |
| Postabsorptive metabolism PC3 | 0.09 | 0.03 | 0.27 | −0.13 | −0.05 | 0.05 | 0.24 | −0.11 | ||
| Postabsorptive metabolism PC4 | −0.04 | −0.04 | −0.06 | 0.07 | −0.11 | −0.01 | 0.13 | 0.05 | 0.02 | |
| Postabsorptive metabolism PC5 | 0.04 | −0.15 | −0.19 | 0.09 | 0.10 | 0.04 | 0.03 | −0.16 | −0.13 | |
| Behavior and stress PC1 | 0.02 | −0.08 | 0.04 | 0.23 | 0.00 | 0.20 | 0.08 | −0.05 | 0.17 | |
| Behavior and stress PC2 | −0.05 | −0.10 | −0.07 | 0.08 | −0.32 | 0.13 | 0.03 | −0.15 | −0.02 | |
| Behavior and stress PC3 | 0.07 | −0.10 | 0.00 | −0.04 | 0.05 | 0.06 | 0.00 | −0.11 | −0.02 | |
| Behavior and stress PC4 | 0.13 | −0.36 | −0.05 | −0.01 | −0.02 | −0.37 | 0.20 | −0.08 | 0.09 | |
| IGF-1 concentration | 0.26 | −0.18 | 0.18 | 0.01 | 0.07 | −0.03 | −0.03 | 0.23 | 0.13 | |
| Calf shape | −0.02 | −0.02 | 0.06 | 0.00 | 0.13 | 0.04 | 0.04 | −0.15 | −0.12 | |
| Eigenvalue | 1.65 | 1.41 | 1.40 | 1.24 | 1.22 | 1.19 | 1.17 | 1.14 | 1.12 | 1.11 |
| Variance explained, % | 9.7 | 8.3 | 8.2 | 7.3 | 7.2 | 7.0 | 6.9 | 6.7 | 6.6 | 6.5 |
The eigenvalue and percentage of variance explained per sPC are provided. Loadings >0.4 and <−0.4 are in bold.